Berkeley, CA, United States of America

Kevin R Haas

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2018)
  • Berkeley, CA (US) (2022 - 2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Kevin R Haas

Introduction

Kevin R Haas is an accomplished inventor based in Berkeley, California. He has made significant contributions to the field of prenatal screening and genetic analysis. With a total of two patents to his name, Haas has developed innovative methods that enhance the accuracy of prenatal testing.

Latest Patents

Haas's latest patents include "Noninvasive prenatal screening using dynamic iterative depth optimization with depth-scaled variance determination." This invention focuses on analyzing fetal and maternal cell-free DNA to determine chromosomal abnormalities in fetuses. The methods described allow for the measurement of dosage of test chromosomes and the determination of statistical significance based on sequencing reads. Another notable patent is the "Copy number variant caller," which utilizes direct targeted sequencing methods and a hidden Markov model to identify copy number variants in test sequencing libraries. These advancements are crucial for improving prenatal diagnostics.

Career Highlights

Throughout his career, Kevin R Haas has worked with prominent companies such as Myriad Women's Health, Inc. and Myriad Genetics, Inc. His experience in these organizations has allowed him to refine his expertise in genetic testing and analysis.

Collaborations

Haas has collaborated with notable colleagues, including Dale E Muzzey and Jeffrey R Tratner. These partnerships have contributed to the development of his innovative patents and have furthered research in the field of prenatal screening.

Conclusion

Kevin R Haas is a notable inventor whose work in prenatal screening and genetic analysis has led to significant advancements in the field. His patents reflect a commitment to improving the accuracy and reliability of prenatal diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…